Literature DB >> 20839332

Monoclonal B cell lymphocytosis: clinical and population perspectives.

Neil E Caporaso1, Gerald E Marti, Ola Landgren, Elizabeth Azzato, J Brice Weinberg, Lynn Goldin, Tait Shanafelt.   

Abstract

Monoclonal B Cell Lymphocytosis (MBL) refers to clones of CLL-like cells that exhibit CLL characteristics that fall short of the numbers required for CLL diagnosis. Data from large CLL kindreds document increased prevalence of MBL suggesting a genetic contribution to its etiology. The molecular features that favor progression of MBL to CLL are poorly understood but an elevated B-cell count is a risk factor for progression. An important consideration when evaluating volunteers from CLL families who are willing to donate bone marrow is that MBL be ruled out since the MBL donor clone could result in a second CLL in the recipient. Further studies of MBL are needed to identify the molecular features and how they evolve during progression. Published 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20839332      PMCID: PMC7282703          DOI: 10.1002/cyto.b.20555

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  43 in total

1.  Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population.

Authors:  Youn K Shim; Robert F Vogt; Dan Middleton; Fatima Abbasi; Barbara Slade; Kyung Y Lee; Gerald E Marti
Journal:  Cytometry B Clin Cytom       Date:  2007-09       Impact factor: 3.058

2.  Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis.

Authors:  Dominick Amato; David G Oscier; Zadie Davis; Sarah Mould; Jianing Zheng; Elena Kolomietz; Chen Wang
Journal:  Am J Clin Pathol       Date:  2007-08       Impact factor: 2.493

3.  Monoclonal B-cell lymphocytosis: definitions and natural history.

Authors:  Tait Shanafelt; Curtis A Hanson
Journal:  Leuk Lymphoma       Date:  2009-03

4.  The proposed diagnostic criteria change for chronic lymphocytic leukemia: unintended consequences?

Authors:  Curtis A Hanson; Paul J Kurtin; Ahmet Dogan
Journal:  Blood       Date:  2009-06-18       Impact factor: 22.113

5.  B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia.

Authors:  Gerald E Marti; Patricia Carter; Fatima Abbasi; Glennelle C Washington; Nisha Jain; Vincent E Zenger; Naoko Ishibe; Lynn Goldin; Laura Fontaine; Nancy Weissman; Maria Sgambati; Guy Fauget; Pablo Bertin; Robert F Vogt; Barbara Slade; Philip D Noguchi; M A Stetler-Stevenson; Neil Caporaso
Journal:  Cytometry B Clin Cytom       Date:  2003-03       Impact factor: 3.058

6.  Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.

Authors:  Sarah S Fung; Kortney L Hillier; Chantal S Leger; Irwin Sandhu; Linda M Vickars; Paul F Galbraith; Charles H Li; Heather A Leitch
Journal:  Leuk Lymphoma       Date:  2007-06

Review 7.  The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.

Authors:  Andy C Rawstron; Fiona Bennett; Peter Hillmen
Journal:  Br J Haematol       Date:  2007-12       Impact factor: 6.998

8.  Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.

Authors:  Graça M Dores; William F Anderson; Rochelle E Curtis; Ola Landgren; Evgenia Ostroumova; Elizabeth C Bluhm; Charles S Rabkin; Susan S Devesa; Martha S Linet
Journal:  Br J Haematol       Date:  2007-10-17       Impact factor: 6.998

9.  Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.

Authors:  Lynn R Goldin; Ruth M Pfeiffer; Xinjun Li; Kari Hemminki
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

10.  A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.

Authors:  Gabrielle S Sellick; Lynn R Goldin; Ruth W Wild; Susan L Slager; Laura Ressenti; Sara S Strom; Martin J S Dyer; Francesca R Mauro; Gerald E Marti; Stephen Fuller; Matthew Lyttelton; Thomas J Kipps; Michael J Keating; Timothy G Call; Daniel Catovsky; Neil Caporaso; Richard S Houlston
Journal:  Blood       Date:  2007-08-08       Impact factor: 22.113

View more
  3 in total

1.  Case study interpretation--Portland: Case 1. Hairy cell leukemia with CLL-like monoclonal B lymphocytosis.

Authors:  Prashant Tembhare; Constance M Yuan; Liqiang Xi; Gerald Marti; Mark Raffeld; Maryalice Stetler-Stevenson
Journal:  Cytometry B Clin Cytom       Date:  2012-03-19       Impact factor: 3.058

2.  HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis.

Authors:  María García-Álvarez; Miguel Alcoceba; Miriam López-Parra; Noemí Puig; Alicia Antón; Ana Balanzategui; Isabel Prieto-Conde; Cristina Jiménez; María E Sarasquete; M Carmen Chillón; María Laura Gutiérrez; Rocío Corral; José María Alonso; José Antonio Queizán; Julia Vidán; Emilia Pardal; María Jesús Peñarrubia; José M Bastida; Ramón García-Sanz; Luis Marín; Marcos González
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

3.  Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).

Authors:  Siddha Kasar; Chingiz Underbayev; Moinuddin Hassan; Ilko Ilev; Heba Degheidy; Steven Bauer; Gerald Marti; Carol Lutz; Elizabeth Raveche; Mona Batish
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.